Scholars Central

Conference abstractPublished 26 Aug 2013

Cyclin dependent kinase 5 (Cdk5) inhibitory peptides, (CIP, P5), inhibit specifically the deregulation of Cdk5 involved in AD model mice and prevent the AD phenotypes

Authors: Harish C. Pant

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

T he Biology of Neurodegeneration program evolved in our laboratory studying the basic biology of neuronal cytoskeletal protein phosphorylation regulation during development and normal function in the adult. To understand the molecular basis of neurodegeneration our major focus has been to study the regulation of compartment-specific patterns of cytoskeletal protein phosphorylation in neuronal perikarya and axons. We have demonstrated that phosphorylation of the numerous acceptor sites on neuronal intermediate filament proteins (NIFPs) as neurofilaments (NFs) was tightly regulated topographically and generally confined to the axonal compartment. It was recognized that in neurodegenerative disorders such as Alzheimer?s disease (AD) and Amyotrophic lateral sclerosis (ALS), the pathology was characterized by an accumulation of aberrantly and hyper- phosphorylated cytoskeletal proteins in cell bodies, suggesting that topographic regulation had been compromised. This led the discovery of neuronal cyclin dependent kinase 5 (Cdk5). Our studies of neurodegeneration in cell culture and model mice with emphasis on specific neuronal protein kinases, (Cdk5), that targets numerous neuronal proteins including cytoskeletal proteins, which when deregulated, may be responsible for the pathology seen in neurodegeneration. In cell systems, neuronal stress leads to deregulated kinases, for example, deregulation of Cdk5, accompanied by abnormal cytoskeletal protein phosphorylation and cell death characteristic of neurodegeneration. Recently we have developed peptides derived from, p35, a neuron specific activator of Cdk5, for deregulated Cdk5 activity which rescue cells in vitro from this stress induced pathology and in vivo , in AD model mice. We have investigated (1) how cytoskeletal protein phosphorylation is topographically and tightly regulated in neurons? (2) What factors are responsible for this deregulation? and (3) treated mouse models of AD therapeutically with peptide that specifically inhibit deregulated Cdk5.

Subjects

Engineering

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Tissue Science and Engineering.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Tissue Science and Engineering
  • SubjectEngineering
  • BylineArticles whose byline prints “Harish C. Pant”